niacin ER

Trials studying niacin ER

• phase2A Study of Psilocybin for Major Depressive Disorder (MDD)completedn=347
• —Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russiarecruitingn=2,382
• phase1PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)terminatedn=60
• phase3Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)terminatedn=1,173
• phase3To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)completedn=1,220
• phase1A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphomaterminatedn=20
• phase4Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Diseaseterminatedn=32